Antiplatelet Therapy and Cardiovascular Diseases

37 та иш

Efficacy of ticagrelol in patients with chronic coronary syndrome and type 2 diabetes mellitus after percutaneous coronary interventions
D. Orziev, A. Abdullaev, Bakhromkhon Alyavi +1
МақолаAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20230 иқтибос
ABI
Effect of combined carriage of polymorphic markers ApoE (Ε2/Ε3/Ε4) and ApoA1 (G-75A) on the ApoB/ApoA-I ratio in CAD patients in the Uzbek population
Р Алиева, Aleksandr B. Shek, А. А. Абдуллаев +4
МақолаAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20230 иқтибос
ABI
The state of the prostacyclin-thromboxane system in patients after aorto-coronary bypass surgery
R. Yu. Kattakhanova, U. N. Kanataeva
МақолаAntiplatelet Therapy and Cardiovascular DiseasesBIO Web of Conferences20230 иқтибос
ABI
The Impact of Cholesterol on Stroke Outcomes: A Cross-Sectional Analysis in Central Java
Yulita Maulani, TOIROV Abdukhamit Suvonovich, Emma Ismawatie +1
МақолаAcute Ischemic Stroke ManagementSriwijaya Journal of Neurology20240 иқтибос
ABI
MODERN SOLUTIONS FOR THE USE OF ANTICOAGULANTS IN MYOCARDIAL INFARCTION AND ARRHYTHMIAS
Turayev H.N, Khurramov Bobir Kholmurodovich
МақолаAtrial Fibrillation Management and OutcomesJournal of Medical Genetics and Clinical Biology20250 иқтибос
ABI
Evaluation of the efficacy of treatment using SGLT2 inhibitors in patients with acute myocardial infarction
Dilafruz Akhmedova, Раиса Тригулова
МақолаDiabetes Treatment and ManagementAtherosclerosis20250 иқтибос
ABI
DUAL ANTIAGGREGANT TERAPIYANING YURAK-QON TOMIR ASORATLARINI KAMAYTIRISHDAGI O'RNI VA INDIVIDUAL YONDASHUV IMKONIYATLARI
Nematova Nasiba Baxodirxon qizi,Abdulkhamidov Abduvali Alisher o'g'li
МақолаAntiplatelet Therapy and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
DUAL ANTIAGGREGANT TERAPIYANING YURAK-QON TOMIR ASORATLARINI KAMAYTIRISHDAGI O'RNI VA INDIVIDUAL YONDASHUV IMKONIYATLARI
Nematova Nasiba Baxodirxon qizi,Abdulkhamidov Abduvali Alisher o'g'li
МақолаAntiplatelet Therapy and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
CLINICAL AND ANAMNESTIC CHARACTERISTICS OF ISCHEMIC HEART DISEASE IN PATIENTS WHO UNDERWENT CORONARY ARTERY BYPASS GRAFTING AND THEIR IMPORTANCE FOR ASSESSING PERIOPERATIVE RISK
Akobir B. Mukhammedov, Usmon Bebitovich Oltiyev
МақолаCardiac, Anesthesia and Surgical OutcomesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
CLINICAL AND ANAMNESTIC CHARACTERISTICS OF ISCHEMIC HEART DISEASE IN PATIENTS WHO UNDERWENT CORONARY ARTERY BYPASS GRAFTING AND THEIR IMPORTANCE FOR ASSESSING PERIOPERATIVE RISK
Akobir B. Mukhammedov, Usmon Bebitovich Oltiyev
МақолаCardiac, Anesthesia and Surgical OutcomesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
Prognostic Factors And Efficacy Of Antiplatelet Therapy In Patients With Chronic Ischemic Heart Disease
Tolibjonov Dilmurod Tolibjonovich, Yuldashov Farrux Shuxratovich
МақолаBiomarkers in Disease MechanismsFrontline Medical Sciences and Pharmaceutical Journal20250 иқтибос
ABI
Therapy After Percutaneous Coronary Intervention in Chronic Coronary Disease: A Practical Review for Internal Medicine and Interventional Cardiology
Akramov Bekhzod Bakhromjon o'gli
МақолаLipoproteins and Cardiovascular HealthThe American Journal of Medical Sciences and Pharmaceutical Research20260 иқтибос
ABI